drugset

drugset / Trial / NCT00965978

A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation

NCT00965978 ↗

Phase 1 Completed 48 enrolled Astellas Pharma Inc Ono Pharma USA Inc · collab

RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the study is to evaluate the effects of food intake on the plasma concentration profile of YNO-5920/YM529 in post menopausal women.

Timeline

Start: 2009-07
Primary completion: 2009-09
Completion: 2009-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Minodronic acid	Small molecule	—	Oral

Indications